Evidence map›Paper›PMID 37213487›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2023

Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA Nephropathy.

Rikako Oki, Kohei Unagami, Jun Kakogawa, Hiroko Beppu, Taro Banno, Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kazuya Omoto, Kumiko Kitajima and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Rikako OkiDepartment of Organ Transplant Medicine, Tokyo Women's Medical University, Shinjuku, Japan.
Kohei UnagamiDepartment of Organ Transplant Medicine, Tokyo Women's Medical University, Shinjuku, Japan.
Jun KakogawaDepartment of Obstetrics and Gynecology, Tokyo Women's Medical University, Shinjuku, Japan.
Hiroko BeppuDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Taro BannoDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Takafumi YagisawaDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Taichi KanzawaDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Toshihito HiraiDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Kazuya OmotoDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Kumiko KitajimaDepartment of Organ Transplant Medicine, Tokyo Women's Medical University, Shinjuku, Japan.
Hiroki ShirakawaDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Junichi HoshinoDepartment of Nephrology, Tokyo Women's Medical University, Shinjuku, Japan.
Toshio TakagiDepartment of Urology, Tokyo Women's Medical University, Shinjuku, Japan.
Hideki IshidaDepartment of Organ Transplant Medicine, Tokyo Women's Medical University, Shinjuku, Japan.
Tokyo Women's Medical University · JPOhkubo Hospital · JPOrgan Technologies (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy in kidney transplantation (KT) recipients has been challenging because of the high risk of maternal, fetal, and renal complications. Although patients with immunoglobulin A nephropathy (IgAN)-chronic kidney disease (CKD) are at a high risk for hypertension in pregnancy (HIP), the maternal risk in KT recipients with IgAN as the etiology remains unclear. We retrospectively reviewed the medical records of pregnant KT recipients who delivered at our hospital. The incidence of maternal and fetal complications and the impact on kidney allografts between the group with IgAN as the primary kidney disease and the group with other primary diseases were compared. The analysis included 73 pregnancies in 64 KT recipients. The IgAN group had a higher incidence of HIP than the non-IgAN group (69% vs. 40%,

Indexed as

Glomerulonephritis, IGAKidney Failure, ChronicKidney TransplantationPregnancy ComplicationsAllograftsFemaleGraft SurvivalHumansKidneyPregnancyRetrospective Studiesgraft survivalIgA nephropathykidney transplantationpregnancypregnancy complications

Identifiers

PMID37213487
PMCPMC10193387
OpenAlexW4377221258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.